Find clinical trials for Adenocarcinoma in Austin, TX

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Pancreatic Cancer
Colorectal Cancer
Stomach Cancer
Prostatic Cancer
Esophageal Cancer

Adenocarcinoma trials near Austin, TX, USA:

Efficacy of EsoGuard Assay on Esophageal Surface Cells Collected With EsoCheck vs EGD for the Diagnosis of BE or EAC (ESOGUARDBE2)

Barrett's Esophagus (BE), with or without dysplasia, and esophageal adenocarcinoma (EAC) as compared to Esophagogastroduodenoscopy (EGD) plu...

Esophageal Adenocarcinoma
Barretts Esophagus With Dysplasia
Diagnostic Test: Esophagogastroduodenoscopy
Device: EsoGuard (lab assay)
Lucid Diagnostics

Austin, Texas, United States and 37 other locations

The purpose of this study is to look at the efficacy and safety of Irinotecan liposome injection in combination with other approved drugs used for ca...

Active, not recruiting
Metastatic Adenocarcinoma of the Pancreas
Drug: Leucovorin
Drug: Gemcitabine

Phase 3


Austin, Texas, United States and 199 other locations

Evaluate the safety and tolerability of RMC-6236 in adults with specific RAS mutant advanced solid tumors.

Pancreatic Ductal Adenocarcinoma (PDAC)
Non-small Cell Lung Cancer (NSCLC)
Drug: RMC-6236

Phase 1

Revolution Medicines
Revolution Medicines

Austin, Texas, United States and 14 other locations

This is a phase 1 dose escalation trial of ZM008, an anti-LLT1 antibody as a single agent followed by combination with Pembrolizumab in patients with...

Pancreas Adenocarcinoma
High Grade Ovarian Serous Adenocarcinoma
Biological: ZM008

Phase 1

Zumutor Biologics Inc.

Austin, Texas, United States and 2 other locations

This study looked at how effective the study drug (tepotinib) was at stopping the growth and spread of lung cancer. This study also measures a number...

Active, not recruiting
Lung Adenocarcinoma Stage IIIB/IV
Advanced (Stage IIIB/IV) Non-small Cell Lung Cancer (NSCLC) With MET Exon 14 (METex14) Skipping Alterations or MET Amplification
Drug: Tepotinib

Phase 2

Merck KGaA (EMD Serono)
Merck KGaA (EMD Serono)

Austin, Texas, United States and 176 other locations

Study to compare the safety and efficacy of oregovomab versus placebo, administered in combination with specific cycles of a standard six-cycle chemo...

Active, not recruiting
Fallopian Tube Adenocarcinoma
Fallopian Tube Serous Adenocarcinoma
Drug: Paclitaxel
Drug: Carboplatin

Phase 3


Austin, Texas, United States and 148 other locations

Locations recently updated

The main objective of Part 1 is to evaluate the safety and tolerability of bemarituzumab plus 5-fluorouracil, leucovorin, and oxaliplatin (mFOLFOX6)...

Gastroesophageal Junction Adenocarcinoma
Gastric Cancer
Other: Placebo
Drug: Nivolumab

Phase 3


Austin, Texas, United States and 329 other locations

This is an open label Phase I/IIa, First in Human trial of TST001, a recombinant humanized anti-Claudin 18.2 (CLDN18.2) IgG1 monoclonal antibody as m...

Advanced Cancer
Gastric Cancer
Drug: Albumin-Bound Paclitaxel
Drug: Gemcitabine

Phase 1, Phase 2


Austin, Texas, United States and 18 other locations

This study will be a prospective analysis conducted by Geneoscopy Inc. to evaluate the Colosense test, which is a multi-target stool RNA test for col...

Active, not recruiting
Advanced Adenocarcinoma
Polyp of Colon
Diagnostic Test: Colosense Stool Sample Collection Kit

Austin, Texas, United States and 1 other location

This study will assess the safety and efficacy of avutometinib (VS-6766) monotherapy and in combination with defactinib in subjects with recurrent Lo...

Active, not recruiting
Low Grade Ovarian Serous Adenocarcinoma
Ovarian Cancer
Drug: avutometinib (VS-6766) and defactinib
Drug: avutometinib (VS-6766)

Phase 2


Austin, Texas, United States and 46 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems